Le Lézard
Classified in: Health
Subjects: VET, CSR

Peace Pole Dedication at Shaklee Corporation


PLEASANTON, Calif., Sept. 26, 2019 /PRNewswire/ -- Shaklee Corporation installed a Peace Pole, a prominent international symbol and monument to peace, at their global headquarters in Pleasanton, CA. A dedication ceremony took place on Thursday, September 19 to commemorate International Day of Peace and during the Shaklee New Directors Conference, where members of the Shaklee Family were recognized for their contributions in helping their communities create healthier lives.

Shaklee Chairman and Chief Executive Officer, Roger Barnett, with Fumi Johns Stewart. Veteran Danny Garcia along with Shaklee Family members participated in the Peace Pole dedication.

Peace Poles are crafted by May Peace Prevail on Earth International, an inclusive, all embracing nonprofit organization associated with the Department of Public Information at the United Nations. Their grassroots global movement aims to bring people of various cultures, faith traditions, and political ideals together as one united heart and mind.

May Peace Prevail on Earth International Executive Director, Fumi Johns Stewart explains that "Planting a Peace Pole is a way of spurring people to inspire, awaken, and uplift the human consciousness around the world. It is very fitting to have a Peace Pole awarded to Shaklee, a company's whose mission is to give people the opportunity to live a life of energy, meaning, and purpose."

Fumi along with veteran and peace activist, Danny Garcia, presented the Peace Pole to Shaklee Chairman and Chief Executive Officer, Roger Barnett.

About Shaklee
Since its inception, Shaklee Corporation has combined breakthrough scientific research with pure, safe, and proven ingredients to develop the world's most cutting-edge and life-enhancing health products. Founded by Dr. Forrest C. Shaklee, who developed the first multivitamin in the U.S. 100 years ago, Shaklee is a leading health and wellness company with a long history of pioneering advances in nutritional science. Shaklee products are backed by over 135 clinical studies, published papers, and scientific presentations that show they make a difference in your health. Shaklee is one of the most well-established names in the nutritional supplement and direct selling industries with over 2 million members worldwide.

 

Shaklee Corporation Creating Healthier Lives

SOURCE Shaklee Corporation


These press releases may also interest you

at 02:59
Immunovia's new lab staffed and operational after rapid implementation
Immunovia (STOCKHOLM: IMMNOV), the diagnostics company seeking to increase pancreatic cancer survival through early detection, today offers an update on its new lab in Research Triangle Park, USA.  Immunovia announced on 29 April the company's...

at 02:23
Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout
Sobi® today announced the initiation of a rolling Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for SEL-212. The submission is based on the results of the DISSOLVE I and II pivotal studies. SEL-212 is an...

at 02:00
Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw
Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the potential for an automated system to deliver genomic profiles of fetal cells that is highly concordant with the genomic analysis obtained from...

at 01:35
4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth
4Moving Biotech (4MB), a clinical-stage subsidiary of 4P-Pharma specializing in immuno-inflammation and osteoarthritis, is pleased to announce the appointment of Luc Boblet as Chief Executive Officer. The company, having successfully completed its...

at 01:00
Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroendocrine tumors based on positive CABINET Phase III trial
 Decision adds to existing collaboration agreement with Exelixis, permitting Ipsen to seek potential marketing authorizations for Cabometyx® (cabozantinib) in advanced pancreatic and extra pancreatic neuroendocrine tumors outside of the U.S. and...

at 01:00
The Bradford Exchange Mint Honors the New Princess of Wales
Beautiful, charming, and caring, Catherine Middleton seemed born to be a princess. She met Prince William at university, and their fairy-tale romance of prince and commoner captured the hearts of millions. Married at Westminster Abbey on 29 April...

More news about Health...


News published on and distributed by: